What therapeutic areas does CHARTWELL RX focus on?

CHARTWELL RX focuses primarily on Cardiovascular and Neurology and 1 other therapeutic areas.

Data updated: Jul 17, 2026

CHARTWELL RX

Q: What drugs does CHARTWELL RX make?

CHARTWELL RX has 342 FDA-approved drugs including ACTICLATE, CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE, PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE.

Generics

Cardiovascular Neurology Infectious Disease

CHARTWELL RX is a generic drug manufacturer focused on Cardiovascular, Neurology, Infectious Disease. Key products include ACTICLATE.

1971

Since

342

Drugs

Trials

New Drugs (2yr)

Modality:

5 Small Molecules

CHARTWELL RX's Key Drugs

CHARTWELL RX's core commercial portfolio centers on ACTICLATE, CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE, PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE, spanning Cardiovascular and Neurology — its most strategically important drugs approved in the last 15 years.

ACTICLATE

Infectious Disease

Rocky Mountain Spotted Fever

Approved 2014

CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE

Gastrointestinal

Gastrointestinal Disorder

Approved 2020

PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE

Metabolic

Type 2 Diabetes

ATP-sensitive potassium channel Approved 2013

FENOFIBRIC ACID

Metabolic

Hypertriglyceridemia

PPAR alpha Approved 2013

CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE

Immunology

Plaque Psoriasis

Approved 2013

CHARTWELL RX's Recent FDA Approvals

CHARTWELL RX secured 1 new FDA approval for novel drugs (NDA/BLA) in the last two years.

FAMOTIDINE NDA

2025-07-16

famotidine

1 INDICATIONS AND USAGE Famotidine tablets are indicated in adult and pediatric patients 40 kg and greater for the treatment of: • active duodenal ulcer (DU). • active gastric ulcer (GU). • symptomatic nonerosive gastroesophageal reflux disease (GERD). • erosive esophagitis due to GERD, diagnosed by biopsy. Famotidine tablets are indicated in adults for the: • treatment of pathological hypersecretory conditions (e.g., Zollinger-Ellison syndrome, multiple endocrine neoplasias). • reduction of the risk of duodenal ulcer recurrence. Famotidine tablets are a histamine-2 (H 2 ) receptor antagonist indicated ( 1 ): In adult and pediatric patients 40 kg and greater for the treatment of: • active duodenal ulcer (DU). • active gastric ulcer. • symptomatic nonerosive gastroesophageal reflux disease (GERD). • erosive esophagitis due to GERD, diagnosed by biopsy. In adults for the: • treatment of pathological hypersecretory conditions (e.g., Zollinger-Ellison syndrome, multiple endocrine neoplasias). • reduction of the risk of DU recurrence.

CHARTWELL RX's Therapeutic Areas

CHARTWELL RX's approved drugs and pipeline span 5 therapeutic areas, led by Cardiovascular and Neurology, across 0 biologic and 5 small-molecule drugs. Weighted by commercial stage — approved drugs count most, then late-stage trials.

Cardiovascular 35%

29 drugs

Neurology 25%

21 drugs

Infectious Disease 19%

16 drugs

Dermatology 14%

12 drugs

Respiratory 7%

6 drugs

CHARTWELL RX's Top Competitors

CHARTWELL RX's closest competitors by therapeutic-area and drug-target overlap include B BRAUN, Pfizer, and GE HEALTHCARE. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.

B BRAUN specialty

Infectious Disease, Dermatology, Cardiovascular, Respiratory

Pfizer big-pharma

Infectious Disease, Neurology, Dermatology

GE HEALTHCARE specialty

Neurology, Cardiovascular, Infectious Disease, Respiratory

Merck big-pharma

Infectious Disease, Cardiovascular, Respiratory

Baxter specialty

Infectious Disease, Cardiovascular, Dermatology